David Kramer: The first US production in 30 years of molybdenum-99, the parent isotope of the most widely used medical radioisotope, is expected to begin within weeks after federal regulators approved a manufacturing process developed by Wisconsin-based NorthStar Medical Radioisotopes. NorthStar received $25 million in matching funds from DOE for development of the neutron capture process and $14.8 million of an expected $25 million total for its accelerator approach.
Latest from John Shanahan
- Cost of wind, solar, nuclear, coal (Andrew Kenny) South Africa
- The miracle of carbon dioxide and water (John Shanahan) USofA
- Four priorities about unscientific claims of man-made climate change and energy (Viv Forbes) Australia
- Why nuclear is inherently safe (Michael Shellenberger) USofA
- Reality versus Climate Alarmism (John Shanahan) USofA